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Demographic trajectories for supercentenarians 
 
Abstract
A fundamental question in aging research concerns the demographic trajectories at the 
highest ages, especially for supercentenarians (persons aged 110 or more). We wish to 
demonstrate that the Weon model enables scientists to describe the demographic 
trajectories for supercentenarians. We evaluate the average survival data from the 
modern eight countries and the valid and complete data for supercentenarians from the 
International Database on Longevity (Robine and Vaupel, (2002) North American 
Actuarial Journal 6, 54-63). The results suggest that the Weon model predicts the 
maximum longevity to exist around ages 120-130, which indicates that there is an 
intrinsic limit to human longevity, and that the Weon model allows the best possible 
description of the demographic trajectories for supercentenarians. 
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1. Introduction 
Fundamental studies of the aging process have lately attracted the interest of 
researchers in a variety of disciplines, linking ideas and theories from such diverse 
fields as biochemistry to mathematics (1). The fundamental model of population 
biology is the Gompertz model (2), in which the human mortality rate increases roughly 
exponentially with increasing age at senescence. The Gompertz model is most 
commonly employed to compare mortality rates between different populations (3). 
However, no mathematical model so far, including the Gompertz model, has been 
suggested that can perfectly approximate the development of the mortality rate over the 
total life span (4). Particularly in modern research findings, it seems to be obvious that 
the mortality rate does not increase according to the Gompertz model at the highest ages 
(5-7), and this deviation from the Gompertz model is a great puzzle to demographers, 
biologists and gerontologists. In order to describe the human demographic trajectories, 
the Weon model has been proposed by Weon, who has established the concept, model, 
methodology, generality, definition of maximum longevity and principle in a series of 
papers (the pre-prints are available at arXiv/q-bio.PE/0402011, 0402013, 0402034, 
0403010 and 0403017; the latter two papers are recommended).
The demographic trajectories at the highest ages are a fundamental question for 
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studying aging and longevity, especially for supercentenarians. For example, some 
researchers have suggested the mortality curves tending but never reaching a plateau or 
a ceiling of mortality (8-10), whereas others have suggested that the mortality curves 
could decrease after having reached a maximum (5-7). Specifically, the mortality curves 
for higher ages (110+) are essential to understand the maximum longevity for humans. 
According to the Weon model, the quadratic expression of the age-dependent shape 
parameter for ages 80-109 is valid with a certain degree of university in many modern 
developed countries (see arXiv/q-bio.PE/0403010), which enables us to predict that the 
mortality rate decreases after a plateau around ages 110-115 and the maximum 
longevity emerges around ages 120-130. If the quadratic expression is still valid for 
ages 110+, we are able to describe the mortality curves at the highest ages. The 
trajectories of the mortality dynamics (deceleration, plateau and decrease) at the highest 
ages by the Weon model seem to be consistent with other assertions (5-7, 11).  
In this paper, we wish to evaluate the validity of the Weon model. The aim of 
this study is to demonstrate whether or not the Weon model enables scientists to 
describe the demographic trajectories for supercentenarians. The validity can be 
evaluated by i) the prediction for ages 110+ from the data for ages 80-109, ii) the 
estimation of the combined data for ages 80-109 and for ages 110+ (supercentenarians) 
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and iii) the estimation of the only data for ages 110+ (supercentenarians). This study is 
based upon the number of supercentenarians by Robine and Vaupel (6, 7) and the Weon 
model most recently proposed by Weon. Firstly we wish to summarize the Weon model 
and secondly we wish to apply the Weon model to evaluate the average survival data 
from the modern eight countries and the valid and complete data for supercentenarians 
from the International Database on Longevity (7). In particular, the age dependence of 
the shape parameter for ages 80+ inevitably leads to the maximum longevity, which 
indicates that there is an intrinsic limit to human longevity. All demographic trajectories 
for human longevity can be explained by the complemetarity between the aging and 
longevity tendencies. 
 
2. Materials and Method 
2.1. Demographic functions 
Three demographic functions are particularly useful (12): the density function, 
the survival function and the mortality function; Let f  be the (probability) density 
function describing the distribution of life spans in a population. The cumulative density 
function, F , gives the probability that an individual dies before surpassing age t  
(indicating a continuous variable). The survival function, s , gives the complementary 
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probability ( Fs −= 1 ) that an individual is still alive at age t . The mortality function, 
m , is defined as the ratio of the density and survival functions ( sfm /= ). Thus, the 
mortality function gives the probability density at age t  conditional on survival to that 
age. In life table notation, the probability of surviving to age x , which indicates a 
discrete variable, s , would be denoted as 0/ llx . The continuous density function, f , 
would be replaced by the discrete function, xd  (or 0/ ld x ), which gives the number (or 
population) of life table deaths in age interval from x  to 1+x . Finally, the mortality 
function, m , would be written in the life table as xm  and is known to demographers 
and actuaries as the force of mortality. 
 
2.2. Demographic data 
We use the average survival data for ages 0-109 from the eight countries, 
Denmark, England & Wales, Finland, France, Japan, Netherlands, Norway and Sweden. 
Demographic data, the period life tables (for all sexes, 1x1, between 1997-2001), for the 
eight countries were taken from the Human Mortality Database (13). The eight 
countries were chosen to compare the IDL (International Database on Longevity) 
database limited to the nine countries (the eight countries + Belgium) for the valid and 
complete data for Supercentenarians (110-122 years) (we used the IDL3 lists in ref. 7). 
We excluded Belgium from the average data, since there was no demographic data for 
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Belgium in the Human Mortality Database, but we expect that there are little differences 
of the average data, regardless of whether the average data include Belgium or not.  
 
3. Weon model 
3.1. Concept 
The original concept was obtained as follows: typical human survival curves 
show i) a rapid decrease in survival in the first few years of life and ii) a relatively 
steady decrease and then an abrupt decrease near death thereafter. Interestingly, the 
former behavior resembles the Weibull survival function with 1<β  and the latter 
behavior seems to follow the case of 1>>β . With this in mind, it could be assumed 
that shape parameter is a function of age (see arXiv/q-bio.PE/0402011). It is especially 
noted that the shape parameter can indicate a ‘rectangularity’ of the survival curve. The 
reason for this is that as the value of the shape parameter becomes a high value, the 
shape of the survival curve approaches a further rectangular shape. 
 
3.2. Model 
The Weon model is derived from the Weibull model (14) and it is simply 
described by two parameters, the age-dependent shape parameter and the characteristic 
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life. The age-dependent shape parameter enables us to model the survival and mortality 
functions and it is expressed as follows, 
 
))/(exp( βαts −=  [1] 
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where α  denotes the characteristic life (or the scale parameter, α=t  when 
)1exp(−=s ) and β  denotes the shape parameter as a “function of age”. The Weon 
model is completely different with the Weibull model in the age dependence of the 
shape parameter. The fact that the shape parameter for humans is a function of age is 
valid with a certain degree of universality in many countries (see arXiv/q-
bio.PE/0402011 and 0403010). The density function by the Weon model can be 
expressed as the multiplication of the survival and mortality functions by the 
mathematical relationship of ‘ smf ×= ’. 
 
3.3. Methodology 
We could evaluate the age dependence of the shape parameter to determine an 
adequate mathematical expression of the shape parameter, after determination of the 
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characteristic life graphically in the survival curve. Conveniently, the value of the 
characteristic life is always found at the duration for the survival to be ‘ )1exp(− ’; this is 
known as the characteristic life. This feature gives the advantage of looking for the 
value of α  simply by graphical analysis of the survival curve. In turn, with the 
observed value of α , we can plot the shape parameter as a function of age by the 
mathematical equivalence of ‘ )/ln(/)lnln( αβ ts−= ’. If β  is not constant with age, 
this obviously implies that ‘ β  is a function of age’.  
In empirical practice, we could successfully use a polynomial expression for 
modeling the shape parameter as a function of age: ...2210 +++= tt ββββ , where the 
associated coefficients could be determined by a regression analysis in the plot of shape 
parameter curve. And thus, the derivative of β  is obtained as follows: 
...2/ 21 ++= tdtd βββ , which indicates again that the shape parameter for humans is a 
function of age. Roughly a linear expression is useful for ages 0-80. But for the best fits 
to the demographic data over the total life span; a cubic or a biquadratic expression is 
appropriate for ages 0-20, a linear or a quadratic expression is appropriate for ages 20-
80 and a quadratic expression is appropriate for ages 80+ (see arXiv/q-bio.PE/0403010). 
On the other hand, β  mathematically approaches infinity as the age t  
approaches the value of α  or the denominator ‘ )/ln( αt ’ approaches zero. This feature 
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of β  can leave ‘trace of α ’ in the plot of β , so we can observe variations of β  
and α  at once in the plot of the shape parameters. If β  (except for the mathematical 
singularity or trace of α ) can be expressed by an adequate mathematical function, the 
survival and mortality functions can be calculated by the mathematically expressed β . 
Only two parameters, α  and β , determine the survival and mortality functions. 
 
3.4. Generality 
The Gompertz model (2) and the Weibull model (14) are the most generally 
used models at present (15). Interestingly, the Gompertz model is more commonly used 
to describe biological systems, whereas the Weibull model is more commonly 
applicable to technical devices (15). In the recent paper (see arXiv/q-bio.PE/0403010), 
we could see that the traditional models, the Gompertz and Weibull models, may be 
generalized by the Weon model through the approximate relationship of ‘ β∝mln ’ 
after adulthood (for ages ~20+). The Weon model approximates the Gompertz model 
when ‘ t∝β ’ and the Weibull model when ‘ =β constant’. That is, the Gompertz model 
is a special case of a linear expression for β  and the Weibull model is a special case of 
a constant shape parameter. Particularly, the mortality rate would deviate from the 
Gompertz model when β  has a non-linear behavior (before age ~20 or after age ~80). 
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Thus, β  is a measure of the deviation from the Gompertz model at higher ages. 
 
3.5. Definition of maximum longevity 
In general, the term of “longevity” means the “duration of life”. In a sense, the 
“maximum longevity” can be used to mean the “maximum duration of life” of a given 
population. However, what we know is the “maximum age at death”, which means the 
oldest age at death observed in a given population during a given time period (16). The 
Weon model suggests the simple mathematical definitions of the maximum longevity. 
In principle, the mortality function should be mathematically positive ( 0>m ). 
Therefore, the criterion for the mathematical limit of longevity, implying the maximum 
longevity which is able to be determined by the mortality dynamics in nature, can be 
given by, 
 
)/ln( α
ββ
ttdt
d
−>  [3] 
 
We successfully used a quadratic expression for the description of the shape parameter 
after age 80. Interestingly, the quadratic coefficient ( 2β ) is important to evaluate the 
maximum longevity (see arXiv/q-bio.PE/0403010).  
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On the other hand, perhaps the most common notion of a limit in the study of 
human longevity is the limited-life-span hypothesis, which states that there exists some 
age ω  beyond which there can be no survivors. This hypothesis can be expressed by 
any one of the following three formulas (12): “ 0=f , 0=s  or ∞=
→
m
t ω
lim  ( ω≥t ).” 
By the way, according to the Weon model, the survival function is not zero, although it 
has extremely low values at the highest ages, but the mortality function can be zero at 
the maximum longevity (see arXiv/q-bio.PE/0403017). The Weon model suggests that 
the maximum longevity can be defined as follows: “at ω=t , 0=f  and 0=m , 
because of 0≠s .” In fact it is possible that the survival rate approaches zero but it is 
not zero. Even at the maximum longevity (ω ), the survival function need not be always 
zero. Instead, the decrease rate of the survival rate with age ( dtds /− ; the minus 
indicates the decrease) should be zero at the maximum longevity. This means that the 
density function ( dtdsf /−= ) should be zero and thus the mortality function 
( sfm /= ) should be zero at the maximum longevity, since the survival function is not 
zero ( 0≠s ). Therefore, the maximum longevity can be simply defined as follows, 
 
0=−
dt
ds
 [4] 
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This simple mathematical expression for the maximum longevity makes sense and 
comprehends the definitions by the density and mortality functions as follows: “at 
ω=t , 0=f  and 0=m , because of 0≠s .” The values for the maximum longevity 
calculated from the Eq. [3] and [4] are mathematically identical. In practice, we can 
identify the maximum longevity at the moment that the survival curve should level in 
the plot of the survival curves. The mortality curves extrapolated by the Weon model 
may approach zero at the maximum longevity, which is due to the nature of the density 
function: That is, the decrease rate of the survival function with age ( dtds /− ) or the 
density function should be zero at the maximum longevity (see arXiv/q-
bio.PE/0403017). 
 
3.6. Principle for longevity: complementarity 
The essence of the Weon model is the age dependence of the shape parameter. 
What is the origin of the age-dependent shape parameter? According to the Weon model, 
in principle for the highest value of s  or for longevity at all times, the shape parameter 
should be variable according to the characteristic life; “for longevity, β  increases at 
α<t  but it decreases at α>t .” This is attributable to the nature of biological systems 
to strive to survive healthier and longer (see arXiv/q-bio.PE/0403010).  
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Empirically, the quadratic coefficient ( 2β ) indicates the decrease of β  at 
α>t . Thus, the longevity tends to increase with increasing 2β . On the other hand, the 
mortality dynamics (deceleration, plateau and decrease) are a consequence of the 
decrease of β  at α>t . The quadratic expression is obviously related with the 
mortality dynamics at α>t , which induces the maximum longevity. Interestingly, the 
maximum longevity tends to decrease with increasing quadratic coefficient ( 2β ). It 
seems that the maximum longevity decreases as the longevity tendency increases, which 
indicates the “complementarity principle on longevity”. It is very interesting that the 
reason for longevity may be the reason for limit of longevity in nature. Therefore, the 
age dependence of the shape parameter seems to be governed by the complementarity 
principle on longevity; “for longevity, β  increases at α<t  but it decreases at α>t , 
resulting in that the maximum longevity decreases as the longevity tendency increases 
in nature” (see arXiv/q-bio.PE/0403010). 
On the other hand, it seems that the density function indicates the effectiveness 
for longevity between the survival and mortality functions ( smf ×= ). The mortality 
rate tends to increase with decreasing the survival rate, which is due to the 
complementarity between the survival and mortality functions; “For longevity, 
individuals tend to reduce the mortality rate and strive to improve the survival rate.” As 
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a result, there exists the ‘maximum’ effectiveness between the survival and mortality 
rates at the ‘characteristic life’ (see arXiv/q-bio.PE/0403017).  
If that is the case, it can be suggested that there may be two parts of 
rectangularization for longevity as follows: The survival function is rectangularized by 
the increase of the shape parameter before characteristic life ( α~0 ) – it is the first part. 
The survival function is rectangularized by the decrease of the shape parameter after 
characteristic life ( ωα ~ ) – it is the second part. The first and second parts can be 
overlapped as one rectangularization as the characteristic life approaches the maximum 
longevity ( ωα → ) (see arXiv/q-bio.PE/0403017). This paradigm of rectangularization 
for longevity makes sense and comprehends the conventional paradigm of 
rectangularization (17, 18). 
The principle indicates that there is fundamentally the complemetarity between 
the aging and longevity tendencies. For longevity, “increasing β  at α<t  but 
decreasing β  at α>t ” or “reducing m  and improving s ” are attributable to the 
nature of biological systems to strive to survive healthier and longer. The 
complementarity inevitably leads to the existence of the maximum longevity, which 
indicates that there is an intrinsic limit to longevity. 
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4. Results 
4.1. Analysis of data up to age 109 
We analyze the characteristic life to be 85.18 years in the average survival 
curve as shown in Fig. 1 (a). We verify the age dependence of the shape parameter for 
the average survival data from the eight countries in Fig. 1 (b). Of course, we can see 
the trace of α  in Fig. 1 (b). Especially for ages 80-109, we expect the age dependence 
of the shape parameter to be a quadratic expression and we obtain a reasonable 
quadratic fit result in Fig. 1 (c). Through modeling the shape parameter as a quadratic 
expression for ages 80-109, we inevitably obtain the mortality curve to decelerate, level, 
decrease and approach zero at a maximum longevity in Fig. 1 (d). In this case, the 
mortality curve shows that the plateau (or the maximum) is predicted to be “0.62 at 110 
years” and the maximum longevity is predicted to be “123.6 years”. It is natural that the 
survival curve should level at the maximum longevity in Fig. 2 (a), through the 
definition of the maximum longevity “ 0/ =− dtds ”. 
 
4.2. Analysis of data including supercentenarians 
We predict the average survival rate to be “ 510278.5 −× ” at age 110 from the 
data for 80-109 in Fig. 2 (a). Assuming the continuity of the survival curve, we are able 
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to adjust the number of supercentenarians from the IDL to be “ 510278.5 −× ” at age 110. 
This adjustment result is seen in Fig. 2 (a) (triangle). From the combined data for ages 
80-109 from the eight countries and for ages 110+ from the IDL, we are able to evaluate 
the age dependence of the shape parameter in Fig. 2 (b). In this case, we verify that the 
quadratic expression is absolutely valid for the shape parameter at the highest ages. The 
consequential trajectories of the survival and mortality curves will show that they 
should have a maximum longevity. For example, the mortality curve is predicted to 
decelerate, level, decrease and approach zero at a maximum longevity in Fig. 2 (c). In 
this case, the mortality curve shows that the plateau (or the maximum) is predicted to be 
“0.62 at 110 years” and the maximum longevity is predicted to be “123.0 years”, which 
is very similar to the predicted from ages 80-109. Therefore, it seems that the survival 
and mortality curves evaluated for ages 80-109 is appropriate for the prediction for ages 
110+. 
 
5. Discussion 
This above analysis is based upon an assumption of the continuity of the 
survival curve; that is, the survival curves will continue over the total life span to follow 
a reasonable mathematical model. At this moment, we wish to discuss the validity of 
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our assumption. 
What does the adjusted value at age 110 mean? In the above analysis, the 
adjusted value for age 110 is estimated to be “ 510278.5 −× ”, which is extrapolated by 
the survival curve through modeling the shape parameter for ages 80-109. It should be 
noted that this value indicates the possibility of persons alive at age 110 in the 
population of the modern eight countries. This adjusted value at age 110 may indicate 
that there are perhaps “~5.3” persons in the population of 100,000 or “~53 per million” 
at age 110. Is this reasonable? However, the valid and complete number of 
supercentenarians in the literature (7) seems to be fewer than the expected number. The 
valid and complete number of persons at age 110 from the nine countries (Belgium, 
Denmark, England & Wales, Finland, France, Japan, Netherlands, Norway and Sweden) 
is “82” according to the IDL (7), which is “~0.28 per million”, considering that the total 
population in the nine countries is ~300 millions (19). There is a significant gap (~200 
times) between the expected population (~53 per million) and the observed population 
(~0.28 per million) at age 110 as shown in Fig. 2 (d). 
At this moment, the adjusted value at age 110 gives us an important insight into 
the number of supercentenarians and the maximum longevity. i) For the case of ~53 per 
million (adjustment), we have to re-estimate the number of supercentenarians. That is, 
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there may be more supercentenarians in the nine countries. Supercentenarians first 
emerged consistently in the 1960s and their numbers have been expanding dramatically 
since (7). Nevertheless, we expect that the number or the probability at age 110 will not 
surpass the value to be expected at age 110 (~53 per million), assuming the continuity 
of the survival curve. In spite of the dramatic increase of the number for 
supercentenarians, the Weon model suggests that there will exist the maximum 
longevity around ages 120-130 as shown in Fig. 2 (c). ii) For the case of ~0.28 per 
million (no adjustment), we have to solve the following question – The average survival 
probability at age 109 from the eight countries is ~80 per million. Then, the only “~0.4 
percent” of survivors at age 109 can be alive at age 110, which indicates that most of 
survivors alive at age 109 should die at age 110. Is this realistic? Why most of survivors 
at age 109 should die at age 110? At present we have no answer for this question about 
the population of supercentenarians. Nevertheless, we can assess the applicability of the 
Weon model to describe the demographic trajectories for supercentenarians. For the 
case of ~0.28 per million (no adjustment), we evaluate again the shape parameter 
pattern for ages 110-122 with no adjusted (raw) data in Fig. 2 (e) and finally we obtain 
the survival curve for ages 110-122 in Fig. 2 (f) (below). In this case, we can see that the 
survival curve decreases with age and levels at the maximum longevity around 120 
20 
years. As a result, the Weon model allows the best possible description of the 
demographic trajectories for supercentenarians through modeling the age-dependent 
shape parameter. 
Finally on all occasions, the results suggest that the Weon model predicts the 
maximum longevity to exist around ages 120-130, which indicates that there is an 
intrinsic limit to human longevity, and that the Weon model allows the best possible 
description of the demographic trajectories for supercentenarians. 
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Figure Legends 
Fig. 1. Demographic trajectories for ages 0-109. (a) The average survival curve for the 
eight countries and the characteristic life observed to be 85.18 years. (b) The shape 
parameter as a function of age for the eight countries. (c) Modeling the shape parameter 
as a quadratic expression between ages 80-109 for the eight countries. (d) Modeling the 
mortality curve through modeling the shape parameter for ages 80-109 for the eight 
countries. 
 
Fig. 2. Demographic trajectories for ages 110+. (a) Modeling the survival curve through 
modeling the shape parameter for ages 80-109 for the eight countries and adjustment of 
IDL data at age 110. (b) Modeling the shape parameter for combined data of the eight 
countries and the IDL data by adjustment. (c) Modeling the mortality curve through 
modeling the shape parameter for combined data of the eight countries and the IDL data 
by adjustment. (d) Modeling the survival curve through modeling the shape parameter 
for ages 80-109 for the eight countries and the IDL data calculated without adjustment. 
(e) Modeling of the shape parameter for ages 110-122 for the IDL data calculated 
without adjustment. (f) Modeling the survival curve through modeling of the shape 
parameter for ages 110-122 for the IDL data calculated without adjustment.
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Fig. 2. (b) 
31 
80 90 100 110 120 130
-0.6
-0.4
-0.2
0.0
0.2
0.4
0.6
0.8
8 countries
+IDL (80-122)
maximum longevity
~123.0 years
decrease
plateau
~0.62 at 110 years
m
o
rta
lit
y
age (year)
  
Fig. 2. (c) 
32 
80 90 100 110 120 130
1E-9
1E-8
1E-7
1E-6
1E-5
1E-4
1E-3
0.01
0.1
1
10
8 countries (80-109)
IDL (110-122)
~200 times
no adjustment of IDL
su
rv
iv
a
l
age (year)
 
Fig. 2. (d) 
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Fig. 2. (e) 
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Fig. 2. (f) 
